Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
FDA pushes plans for drug compounding: more scrutiny for hospital pharmaciesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
FDA strategies to prevent and respond to drug shortages: finding a better way to predict and prevent company closuresStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
Medicare changes include new part d rules and possible cuts to hospitalsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 15, 2016
Health Plans and Drug Companies Dip Their Toes Into Value-Based Pricing: The Pressure Is on P&T Committees to Monitor UtilizationStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 27, 2015
Pharmacies Wrestle With Drug-Tracing Rule: Confusion as Deadline Passes: Paper, Digital, or Web Portal?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 4, 2015
Brand and Generics Companies Unite to Pressure FDA: They Want the Agency to Drop Its Safety-Label Plan and Adopt Their AlternativeStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 30, 2015
Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at IssueStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|October 23, 2014
FDA Accepts Its First Biosimilar Application: However, the Agency's Requirements Are Still UnclearStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
FDA's Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds: Is the Bar Being Set Too High, or Too Low?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 24, 2015
Employers and Drugstores Press for PBM Transparency: A Labor Department Advisory Committee Has Recommended ChangesStephen Barlas
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
FDA pushes plans for drug compounding: more scrutiny for hospital pharmaciesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
FDA strategies to prevent and respond to drug shortages: finding a better way to predict and prevent company closuresStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
Medicare changes include new part d rules and possible cuts to hospitalsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 15, 2016
Health Plans and Drug Companies Dip Their Toes Into Value-Based Pricing: The Pressure Is on P&T Committees to Monitor UtilizationStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 27, 2015
Pharmacies Wrestle With Drug-Tracing Rule: Confusion as Deadline Passes: Paper, Digital, or Web Portal?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 4, 2015
Brand and Generics Companies Unite to Pressure FDA: They Want the Agency to Drop Its Safety-Label Plan and Adopt Their AlternativeStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 30, 2015
Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at IssueStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|October 23, 2014
FDA Accepts Its First Biosimilar Application: However, the Agency's Requirements Are Still UnclearStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
FDA's Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds: Is the Bar Being Set Too High, or Too Low?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 24, 2015
Employers and Drugstores Press for PBM Transparency: A Labor Department Advisory Committee Has Recommended ChangesStephen Barlas
Pageof 15